People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Other Technology, Other Health Care, Healthtech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vitara Biomedical, Inc. | — | Biotechnology | Series B | $70.0M | $63.2M | 2022 |
| Figur8, Inc. | — | Other Technology | Series B | $33.1M | $255.0M | 2023 |
| Superflex, Inc. | — | Other Technology | Series A | $16.4M | $173.4M | 2016 |
| Mytrus, Inc | — | Other Health Care | Seed | $5.7M | $18.6M | 2009 |
| Ancora Medical, Inc. | — | Healthtech | Pre-Seed | $977K | $5.5M | 2017 |
| Mindcrest Inc | — | Other | Pre-Seed | $735K | $17.0M | 2017 |
Manish Kothari at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Manish Kothari on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Kelly | 1 | 7 |
| Ian Ratcliffe | 1 | 6 |
| William Wolf | 1 | 5 |
| Bernard Lyons | 1 | 3 |
| Richard Rubino | 1 | 3 |
| Terry Diamond | 1 | 3 |
| Gregg Dearhammer | 1 | 2 |
| Thomas Todorow | 1 | 2 |
| Aaron Timm | 1 | 2 |
| Hal Katz | 1 | 2 |
| Ted Fjallman | 1 | 2 |
| Carl Cummings | 1 | 1 |
| Monash Kothari | 1 | 1 |
| Brandon Eldredge | 1 | 1 |
| Rosaleen Oskanian | 1 | 1 |
| Harry Genant | 1 | 1 |
| Diem Nguyen | 1 | 1 |
| James McGlone | 1 | 1 |
| Anthony Costello | 1 | 1 |
| Steven Cummings | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.